CLOV Insider Trading

Insider Ownership Percentage: 22.28%
Insider Buying (Last 12 Months): $116,411.60
Insider Selling (Last 12 Months): $1,197,500.00

Clover Health Investments Insider Trading History Chart

This chart shows the insider buying and selling history at Clover Health Investments by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$1.20MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M-$500k$0$500k$1MTotal Insider BuyingTotal Insider Selling

Clover Health Investments Share Price & Price History

Current Price: $3.61
Price Change: Price Increase of +0.25 (7.44%)
As of 03/12/2025 05:00 PM ET

This chart shows the closing price history over time for CLOV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AprMayJunJulAugSepOctNovDecJanFebMar$3.61Closing price on 03/12/25:

SEC Filings (Institutional Ownership Changes) for Clover Health Investments (NASDAQ:CLOV)

19.77% of Clover Health Investments stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CLOV by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$41Mbought$15MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$40M-$20M$0$20M$40MTotal InflowsTotal Outflows
Clover Health Investments logo
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.
Read More on Clover Health Investments

Today's Range

Now: $3.61
Low: $3.44
High: $3.68

50 Day Range

MA: $4.10
Low: $3.13
High: $4.82

52 Week Range

Now: $3.61
Low: $0.61
High: $4.87

Volume

8,584,359 shs

Average Volume

6,490,598 shs

Market Capitalization

$1.84 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2

Who are the company insiders with the largest holdings of Clover Health Investments?

Clover Health Investments' top insider shareholders include:
  1. Brady Patrick Priest (CEO)
  2. Karen Soares (General Counsel)
  3. Anna U Loengard (Director)
  4. Carladenise Armbrister Edwards (Director)
Learn More about top insider investors at Clover Health Investments.

Who are the major institutional investors of Clover Health Investments?

Clover Health Investments' top institutional shareholders include:
  1. Vanguard Group Inc. — 3.91%
  2. Renaissance Technologies LLC — 2.21%
  3. Geode Capital Management LLC — 0.97%
  4. PNC Financial Services Group Inc. — 0.89%
  5. Marshall Wace LLP — 0.75%
  6. Charles Schwab Investment Management Inc. — 0.55%
Learn More about top institutional investors of Clover Health Investments stock.

Which major investors are selling Clover Health Investments stock?

During the previous quarter, CLOV stock was sold by these institutional investors:
  1. Renaissance Technologies LLC
  2. Two Sigma Investments LP
  3. PNC Financial Services Group Inc.
  4. Charles Schwab Investment Management Inc.
  5. Citadel Advisors LLC
  6. Cubist Systematic Strategies LLC
  7. Wedbush Securities Inc.
  8. Connor Clark & Lunn Investment Management Ltd.
During the previous year, company insiders that have sold Clover Health Investments company stock include:
  1. Brady Patrick Priest (CEO)
  2. Karen Soares (General Counsel)
  3. Anna U Loengard (Director)
Learn More investors selling Clover Health Investments stock.

Which major investors are buying Clover Health Investments stock?

Within the last quarter, CLOV stock was acquired by institutional investors including:
  1. Marshall Wace LLP
  2. Millennium Management LLC
  3. Teacher Retirement System of Texas
  4. Schonfeld Strategic Advisors LLC
  5. American Century Companies Inc.
  6. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  7. Vanguard Group Inc.
  8. Simplex Trading LLC